News and Info

Welcome to the News and Info section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed about the latest news and ongoing activities of the organization. This section contains announcements, news stories, press releases, and blogs.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

July 20, 2023

Dr. Pamela Kunz on what’s next after the successful E2211 trial for patients with neuroendocrine tumors

June 30, 2023

The May/June 2023 News from ECOG-ACRIN blog is now available

June 22, 2023

The ECOG-ACRIN Clinical Research Associates (CRA) Core Committee is seeking candidates

June 16, 2023

Media Advisory: Nature Medicine publishes key lessons from NCI-MATCH to guide future precision medicine trials

June 1, 2023

Press Release: ComboMATCH investigators are translating robust pre-clinical evidence for new anti-cancer drug combinations into a series of early-phase clinical trials

May 31, 2023

NCI-MATCH named among five innovative oncology therapies changing the game

May 31, 2023

Your daily guide to ASCO 2023 research presentations by ECOG-ACRIN and PrECOG

May 30, 2023

Group leaders talk with The Cancer Letter about the cisplatin chemotherapy shortage (login required)

May 17, 2023

Press Release: ECOG-ACRIN announces the recipients of its 2023 scientific leadership and mentorship awards

May 11, 2023

Press Release: Historic achievement for the ongoing InPACT penile cancer trialโ€”100 patients enrolled thus far, the most ever to a prospective study in this extremely rare disease

April 29, 2023

A TAILORx post hoc analysis is the first to show racial and ethnic differences in locoregional breast cancer recurrence

April 28, 2023

JAMA Surgery publishes TAILORx analysis showing that racial and ethnic differences in locoregional breast cancer recurrence patterns are prevalent even in a clinical trial population with similar access to care

April 26, 2023

Two new studies shed light on cancer detection in dense breasts as researchers emphasize the need for the TMIST trial

April 26, 2023

An AI algorithm may help better guide oropharynx cancer treatment

April 21, 2023

Lancet Digital Health publishes the first validation of a CT-based deep learning tool for pre-treatment identification of head and neck cancer patients with high-risk, aggressive disease (in the context of the E3311 trial)

April 19, 2023

The March/April 2023 News from ECOG-ACRIN blog is now available

April 7, 2023

American College of Radiology (ACR) leader highlights TMIST mammography trial in testimony supporting NIH funding increase

April 6, 2023

E1411 study chair Mitchell Smith discusses the use of ibrutinib for patients with previously treated mantle cell lymphoma

March 23, 2023

The Spring 2023 advocacy blog Considering Clinical Trials is now available

March 21, 2023

In this video interview, Dr. Neha Vapiwala discusses the INDICATE (EA8191) trial and changing the trajectory of prostate cancer through radiation and imaging techniques

 
ECOG-ACRIN Cancer Research Group